Concepedia

Shoko Kagawa

SK

Statistics

Publications

10

Citations

246

H-Index

10

Active since

2010

Affiliations

University of the Ryukyus(Current)

Moscow Research and Clinical Center for Neuropsychiatry

Shoko Kagawa is an author at University of the Ryukyus specializing in pharmacology, psychopharmacology, and clinical pharmacology.

ORCID

Publications per year

2010–2018

10

Publications

10

Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

Takeshi Suzuki, Kazuo Mihara, A. Nakamura et al. · Therapeutic Drug Monitoring · 2014 · 57 citations

, , +17

Effects of the CYP2D6*10 Allele on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

Takeshi Suzuki, Kazuo Mihara, A. Nakamura et al. · Therapeutic Drug Monitoring · 2010 · 43 citations

, , +16

Relationship Between Plasma Concentrations of Lamotrigine and Its Early Therapeutic Effect of Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder

Shoko Kagawa, Kazuo Mihara, A. Nakamura et al. · Therapeutic Drug Monitoring · 2014 · 31 citations

, , +17

Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of<i>dopamine<scp>D</scp>2 receptor</i>and<i>cytochrome<scp>P</scp>450 2<scp>D</scp>6</i>in Japanese patients with schizophrenia

Goyo Nagai, Kazuo Mihara, A. Nakamura et al. · Psychiatry and Clinical Neurosciences · 2012 · 29 citations · Full text

, , +17

Relationship Between UGT1A4 and UGT2B7 Polymorphisms and the Steady-State Plasma Concentrations of Lamotrigine in Patients With Treatment-Resistant Depressive Disorder Receiving Lamotrigine as Augmentation Therapy

Takeshi Suzuki, Kazuo Mihara, Goyo Nagai et al. · Therapeutic Drug Monitoring · 2018 · 20 citations

, , +17

1–5 of 10